Skip to Content

AC 535 (Ranitidine Hydrochloride 150 mg)

Pill with imprint AC 535 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by ANI Pharmaceuticals, Inc..

Ranitidine is used in the treatment of duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AC 535

Ranitidine hydrochloride 150 mg AC 535

Ranitidine Hydrochloride

Imprint
AC 535
Strength
150 mg
Color
Brown
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
ANI Pharmaceuticals, Inc.
National Drug Code (NDC)
62559-0690

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.